Click here to go to the previous page
Program Code:
373
Date:
Wednesday, June 27, 2012
Time:
3:30 PM to 5:00 PM
EST
CHAIR
:
Brenda Jamerson,
Campbell University College of Pharmacy and Health Sciences, United States
Brenda Jamerson, PharmD is Associate Professor Campbell University College of Pharmacy, Director Clinical Research Center and VAMC GRECC Research Pharmacist. She was previously Director Depression/Dependence at GlaxoSmithKline with responsibilities for program development in the neurosciences area.
|
PRESENTER
(S):
Brenda Jamerson,
Campbell University College of Pharmacy and Health Sciences, United States
Brenda Jamerson, PharmD is Associate Professor Campbell University College of Pharmacy, Director Clinical Research Center and VAMC GRECC Research Pharmacist. She was previously Director Depression/Dependence at GlaxoSmithKline with responsibilities for program development in the neurosciences area.
|
Kelly Larrabee, Cleartrial, LLC, United States
With over a decade of marketing experience, Ms. Gonzalez applies her healthcare, legal, and business acumen to HCG’s long-term strategic branding, aims, and partnerships. In tandem, she guides HCG's social media and diversity strategies for global recruitment.
|
Description
Recruitment and retention of a diverse population in clinical trials is becoming increasingly important. In order to adequately address efficacy and safety targets in specific subsets of the population, clinical trials must include a broad range of participants across the spectrum of race, ethnicity and age. This symposium will present practical insights for clinical trial operational planning that optimizes recruitment and retention of Blacks, Latinos, and geriatric participants in clinical trials.
Learning Objectives:
Identify barriers that impede enrollment of Blacks, Latinos, and geriatric patients in clinical trials
Discuss effective methods and strategies to increase study awareness and improve enrollment and retention of a diverse population into clinical trials
Discuss strategies to achieve cultural competence to support enrollment of a diverse population in clinical trials.